Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zechary Rios"'
Publikováno v:
Trends in Pharmacological Sciences. 38:226-256
Heat shock proteins (HSPs) constitute a large family of proteins involved in protein folding and maturation whose expression is induced by heat shock or other stressors. The major groups are classified based on their molecular weights and include HSP
Autor:
Senyo Agbenowu, Christopher K. Daniels, Alok Bhushan, Zechary Rios, James C. K. Lai, Peter P. Sheridan, Tuoen Liu, Ratan Singh, Mengxiong Li, Shousong Cao, Shawn E. Bearden
Publikováno v:
Cancer Letters. 357:231-241
We previously identified and characterized a 66–68 kDa membrane-associated, tyrosine phosphorylated protein in murine leukemia L1210 cells as HSC70 which is a methotrexate (MTX)-binding protein. In order to further characterize the functional role
Autor:
Zechary Rios, Luke Wojdyla, Neelu Puri, Srijayaprakash B. Uppada, Caleb Shearrow, Amanda L Stone, Joseph T. Devito, Gregory M. Botting, Zachary Crees, Kymberly Harrington, Jennifer Girard
Publikováno v:
Current Pharmaceutical Design. 20:6422-6437
Cancer is a leading cause of death worldwide and an estimated 1 in 4 deaths in the United States is due to cancer. Despite recent advances in cancer treatment, adverse effects related to cancer therapy remain a limiting factor for many patients. The
Autor:
Tuoen Liu, Zechary Rios, Peter P. Sheridan, Christopher K. Daniels, Alok Bhushan, James C. K. Lai, Ratan Singh
Publikováno v:
The FASEB Journal. 28
We previously identified and characterized a 66-68 kDa membrane-associated, tyrosine phosphorylated protein in murine leukemia L1210 cells as HSC70 which is a methotrexate (MTX) - binding protein. We further characterize the functional role of HSC70
Autor:
Luke Wojdyla, Zechary Rios, Ceyda Bertram, Caleb Shearrow, Srijayaprakash B. Uppada, Gregory M. Botting, Neelu Puri
Publikováno v:
Journal of Postgenomics Drug & Biomarker Development.
Traditional chemotherapy is the first treatment option for the majority of cancer patients, but due to harsh and toxic side effects, more targeted therapies are needed. T-oligo is an oligonucleotide homologous to the 3’ overhang of the telomere. It